A POST‐MARKETING SURVEILLANCE STUDY OF 703 PATIENTS TREATED WITH CHIDAMIDE FOR PERIPHERAL T‐CELL LYMPHOMA (PTCL) IN CHINA. HDAC STUDY GROUP OF UNION FOR CHINA LYMPHOMA INVESTIGATORS (UCLI). (June 2017)

• Record Type: Journal Article
• Authors: Ma, J.; Zhu, J.; Shi, Y.K.; Huang, H.Q.; Jiang, W.Q.; Li, W.Y.; Wang, J.H.; Xu, W.; Hou, M.; Jin, Z.M.; Liu, T.; Liu, P.; Zhao, W.L.; Zhang, H.L.; Yang, H.Y.; Zhang, X.; Jin, J.; Li, Z.M.; Qiu, L.G.; Dong, M.; Wang, X.; Zhou, J.F.; Shen, J.Z.; Chen, X.Q.; Song, Y.Q.
• Is Part Of: Hematological oncology. Volume 35(2017)Supplement 2
• Page Start: 250
• Page End: 251
• Publication Date: 2017-06
• Subjects: Hematological oncology -- Periodicals; Hematology; Medical Oncology; 616.99418005
• DOI: 10.1002/hon.2438_114
• Languages: English
• ISSNs: 0278-0232